Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Livzon Pharmaceutical Group Inc Class H (HK:1513)
HKEX:1513
Holding HK:1513?
Track your performance easily
1513 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$21.50 - HK$29.90
Previous CloseHK$24.8
Volume379.94K
Average Volume (3M)500.92K
Market Cap
HK$31.96B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)10.7
Beta0.52
Next Earnings
Oct 22, 2024EPS Estimate
HK$0.59Last Dividend Ex-Date
Jul 08, 2024Dividend Yield5.96%
Share Statistics
EPS (TTM)2.32
Shares OutstandingN/A
10 Day Avg. Volume360,051
30 Day Avg. Volume500,918
Standard Deviation0.10
R-Squared0.19
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.76
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Livzon Pharmaceutical Group News
PremiumCompany Announcements
Livzon Pharmaceutical’s Mid-Year 2024 Results
PremiumCompany Announcements
Livzon Pharmaceutical Schedules Key Board Meeting
PremiumCompany Announcements
Livzon Pharmaceutical Announces Indonesian Joint Venture
PremiumCompany Announcements
Livzon Pharmaceutical Completes Share Cancellation
PremiumCompany Announcements
Livzon Pharmaceutical Corrects Dividend Information
PremiumCompany Announcements
Livzon Pharma Appoints New HK Service Agent
PremiumCompany Announcements
Livzon Pharmaceutical Group’s Resolutions Passed UnanimouslyOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.75% Mutual Funds
1.96% Other Institutional Investors
96.29% Public Companies and
Individual Investors
1513 FAQ
What was Livzon Pharmaceutical Group Inc Class H’s price range in the past 12 months?
Livzon Pharmaceutical Group Inc Class H lowest stock price was HK$21.50 and its highest was HK$29.90 in the past 12 months.
What is Livzon Pharmaceutical Group Inc Class H’s market cap?
Currently, no data Available
When is Livzon Pharmaceutical Group Inc Class H’s upcoming earnings report date?
Livzon Pharmaceutical Group Inc Class H’s upcoming earnings report date is Oct 22, 2024 which is in 51 days.
How were Livzon Pharmaceutical Group Inc Class H’s earnings last quarter?
Livzon Pharmaceutical Group Inc Class H released its earnings results on Aug 22, 2024. The company reported HK$0.627 earnings per share for the quarter, beating the consensus estimate of HK$0.605 by HK$0.022.
Is Livzon Pharmaceutical Group Inc Class H overvalued?
According to Wall Street analysts Livzon Pharmaceutical Group Inc Class H’s price is currently Overvalued.
Does Livzon Pharmaceutical Group Inc Class H pay dividends?
Livzon Pharmaceutical Group Inc Class H pays a Annually dividend of HK$1.46 which represents an annual dividend yield of 5.96%. See more information on Livzon Pharmaceutical Group Inc Class H dividends here
What is Livzon Pharmaceutical Group Inc Class H’s EPS estimate?
Livzon Pharmaceutical Group Inc Class H’s EPS estimate is HK$0.59.
How many shares outstanding does Livzon Pharmaceutical Group Inc Class H have?
Livzon Pharmaceutical Group Inc Class H has 307,052,430 shares outstanding.
What happened to Livzon Pharmaceutical Group Inc Class H’s price movement after its last earnings report?
Livzon Pharmaceutical Group Inc Class H reported an EPS of HK$0.627 in its last earnings report, beating expectations of HK$0.605. Following the earnings report the stock price went down -1.035%.
Which hedge fund is a major shareholder of Livzon Pharmaceutical Group Inc Class H?
Currently, no hedge funds are holding shares in HK:1513
---
Livzon Pharmaceutical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.62%
12-Months-Change
Fundamentals
Return on Equity
14.64%
Trailing 12-Months
Asset Growth
-0.61%
Trailing 12-Months
Company Description
Livzon Pharmaceutical Group Inc Class H
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio primarily comprises of western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drugs address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, as well as blood and hemopoietic system. The Company distributes its products within domestic market and to overseas markets.
---
1513 Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Livzon Pharmaceutical Group
―
Ligand Pharma
―
Amgen
―
Bristol-Myers Squibb
―
GlaxoSmithKline
―
Best Analysts Covering 1513
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+3.83%
reiterated a sell rating 12 months ago
Copying Sean Wu CFA's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +3.83% per trade.
---